PATENT CLAIM ANALYSIS

Application Number: 16210896
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "254000"]

Abstract:
Compositions and methods for inducing pterygium regression from visual axis/central cornea, stabilizing pterygium, treating hyperemia and symptoms in pterygium patients, and treating pterygium recurrence following pterygiectomy are disclosed. The methods include administration of a multikinase inhibitor, an antimetabolite or a combination thereof to patients in need thereof.

Claim (Index 8):
The method of  claim 4 , wherein the ocular implant further comprises one or more pharmaceutically acceptable excipients.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.39474
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15474620', '15991698', '15375820', '15991382', '16131945']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8462606716772602
- 35 USC 102 Novelty (BERT): 0.5908520183643319
- Combined Prediction Score: 0.8207198063459673
- Mean Citation Score: 482.458138
- Max Citation Score: 536.69006
- Similarity Product: 401.21372835572

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test